Evidences of a New Psychobiotic Formulation on Body Composition and Anxiety

被引:46
作者
Colica, Carmela [1 ]
Avolio, Ennio [2 ]
Bollero, Patrizio [3 ]
de Miranda, Renata Costa [4 ,5 ]
Ferraro, Simona [6 ]
Salimei, Paola Sinibaldi [7 ]
De Lorenzo, Antonino [7 ]
Di Renzo, Laura [7 ]
机构
[1] Magna Graecia Univ Catanzaro, CNR, IBFM UOS Germaneto, Campus Salvatore Venuta, I-88100 Catanzaro, Italy
[2] Univ Calabria, Comparat Neuroanat Lab Ecol Dept, I-87030 Cosenza, Italy
[3] Univ Roma Tor Vergata, Dept Syst Med, Via Montpellier 1, I-00133 Rome, Italy
[4] Univ Roma Tor Vergata, PhD Sch Med Surg Appl Sci, Via Montpellier 1, I-00133 Rome, Italy
[5] Minist Educ Brazil, CAPES Fdn, CAPES Scholarship Proc BEX 13264 13 3, BR-70040020 Brasilia, DF, Brazil
[6] Hlth Ctr Srl, Biomed & Nutr Ctr, I-87100 Cosenza, Italy
[7] Univ Roma Tor Vergata, Sect Clin Nutr & Nutrigen, Dept Biomed & Prevent, Via Montpellier 1, I-00133 Rome, Italy
关键词
PROMOTER GENE POLYMORPHISM; GUT MICROBIOTA; INSULIN-RESISTANCE; PHYSICAL-ACTIVITY; FAT MASS; OBESITY; ASSOCIATION; WEIGHT; OVERWEIGHT; IMPACT;
D O I
10.1155/2017/5650627
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Background. Gut microbiota is implied in obesity, because of its ability to harvest energy from diet, and in the regulation of behavior. Given the link between gut microbiota, body composition, obesity, and anxiety, the aim of this study was to evaluate the effects of a new psychobiotic formulation. Methods. Eligible patients were randomly divided into three groups: psychobiotics oral suspension group (POSG); dietary treatment group (DTG); combined treatment group (CTG). All subjects underwent body composition and psychological profile evaluation. Results. Significant changes in body composition parameters in each group were relieved after all treatments. Hamilton anxiety rating scale (HAM-A) highlighted a significant reduction of the total score for all study population after treatments in POSG (p = 0 01) and CTG (p = 0 04). A reduction of HAM-A total score in anxious subjects in POSG or CTG and a significant reduction of positive subjects for HAM-A in POSG (p = 0 03) and in CDG (p = 0 01) were shown. Discussion. Three-week intake of selected POS represents a good approach to solve problems related to obesity and behavior disorders. However, new clinical trials need to be performed on a larger population and for a longer period of treatment before definitive conclusions can be made. This trial is registered with NCT01890070.
引用
收藏
页数:10
相关论文
共 64 条
[1]  
[Anonymous], NUTRIENTS
[2]   Dual-energy X-ray absorptiometry prediction of adipose tissue depots in children and adolescents [J].
Bauer, Jacqueline ;
Thornton, John ;
Heymsfield, Steven ;
Kelly, Kim ;
Ramirez, Alexander ;
Gidwani, Sonia ;
Gallagher, Dympna .
PEDIATRIC RESEARCH, 2012, 72 (04) :420-425
[3]   Impact of consuming a milk drink containing a probiotic on mood and cognition [J].
Benton, D. ;
Williams, C. ;
Brown, A. .
EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2007, 61 (03) :355-361
[4]   Intestinal microbiota, probiotics and mental health: from Metchnikoff to modern advances: Part II - contemporary contextual research [J].
Bested, Alison C. ;
Logan, Alan C. ;
Selhub, Eva M. .
GUT PATHOGENS, 2013, 5
[5]   Risk factors for onset of osteoarthritis of the knee in older adults: a systematic review and meta-analysis [J].
Blagojevic, M. ;
Jinks, C. ;
Jeffery, A. ;
Jordan, K. P. .
OSTEOARTHRITIS AND CARTILAGE, 2010, 18 (01) :24-33
[6]   Impact of the gut microbiota on inflammation, obesity, and metabolic disease [J].
Boulange, Claire L. ;
Neves, Ana Luisa ;
Chilloux, Julien ;
Nicholson, Jeremy K. ;
Dumas, Marc-Emmanuel .
GENOME MEDICINE, 2016, 8
[7]   Obesity and vulnerability of the CNS [J].
Bruce-Keller, Annadora J. ;
Keller, Jeffrey N. ;
Morrison, Christopher D. .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2009, 1792 (05) :395-400
[8]   Adipocytokines in obesity and metabolic disease [J].
Cao, Haiming .
JOURNAL OF ENDOCRINOLOGY, 2014, 220 (02) :T47-T59
[9]   Minireview: Gut Microbiota: The Neglected Endocrine Organ [J].
Clarke, Gerard ;
Stilling, Roman M. ;
Kennedy, Paul J. ;
Stanton, Catherine ;
Cryan, John F. ;
Dinan, Timothy G. .
MOLECULAR ENDOCRINOLOGY, 2014, 28 (08) :1221-1238
[10]   Liraglutide: An Injectable Option for the Management of Obesity [J].
Clements, Jennifer N. ;
Shealy, Kayce M. .
ANNALS OF PHARMACOTHERAPY, 2015, 49 (08) :938-944